Results 191 to 200 of about 3,049 (238)

Recommendations for the use of LDL apheresis

Atherosclerosis, 2008
Plasma exchange has been shown to increase life-expectancy in homozygous familial hypercholesterolaemia (FH) but increasingly is being replaced by LDL apheresis. Several methods are now available for undertaking this procedure, which lowers LDL cholesterol and Lp(a) efficiently and safely when performed weekly or bi-weekly and causes only slight ...
openaire   +3 more sources

Activation of coagulation by a LDL-apheresis device

Blood Coagulation & Fibrinolysis, 1996
LDL-apheresis often induces an almost constant and progressive increase of the differential pressure of plasma flowing through the dextran sulphate cellulose column, reducing the efficacy of the treatment. On two occasions we were able to identify a fibrin plug by immunofluorescence. Our aim was to verify the modification of some coagulation indicators
Nicola Fiotti, Carlo Giansante, Luigi Cattin, M. Fonda, A. Petrucco, S. Calabrese, Paolo Bordin, P. G. Da Col   +7 more
openaire   +3 more sources

Organization and Technical Problems of LDL-apheresis

The International Journal of Artificial Organs, 1993
The Authors consider problems related to technique and organization of LDL-Apher-esis with respect to some particular aspects. They evaluate: a) Technical complexity of procedures both in devices to use and in staff preparation; b) Length of treatment which conditions the other fields of activity; c) Problems in management treatments periodicity ...
Formisano S, N. Scarpato, G. Nappi, Falco C   +3 more
openaire   +3 more sources

LDL Apheresis and Inflammation – Implications for Atherosclerosis

Scandinavian Journal of Immunology, 2012
AbstractLow‐density lipoprotein (LDL) apheresis is an extracorporeal treatment modality used in high‐risk patients when LDL cholesterol levels cannot be reduced adequately with medication. The treatment is highly effective, but could be affected by potential unwanted effects on pro‐ and anti‐inflammatory biomarkers.
Anders Hovland, Tom Eirik Mollnes, Knut Tore Lappegård   +2 more
openaire   +3 more sources

Role of LDL apheresis in the management of hypercholesterolaemia

Transfusion Science, 1993
Abstract It is now established that extracorporeal cholesterol removal is the best means of improving prognosis in patients with homozygous FH and this should be started before atherosclerosis becomes apparent. Anti-human LDL antibodysepharose columns, dextran sulphate-cellulose gel columns and the HELP system are all potent methods of extracorporeal
Gilbert R. Thompson, Yuri Kitano
openaire   +3 more sources

Overview: Techniques and Indications of LDL-Apheresis

Biomaterials, Artificial Cells and Immobilization Biotechnology, 1991
In recent years, LDL-apheresis has emerged to be an efficient treatment of hyperlipidemia in patients who do not respond sufficiently to diet and lipid lowering drugs. A survey of LDL lowering extracorporeal procedures is presented. Among them, to date 5 procedures have been used clinically on a routine basis: unselective plasma exchange, semi ...
Thomas C. G. Bosch, Hans J. Gurland
openaire   +3 more sources

LDL Apheresis in Atherosclerotic Disease with Hyperlipidemia

ASAIO Journal, 1992
Low density lipoprotein (LDL) apheresis was carried out in 28 atherosclerotic patients with clinical signs of poor peripheral circulation and abnormally high LDL levels. The LDL apheresis using extracorporeal adsorption with a dextran sulfate cellulose column (Liposorber, Kaneka, Japan) was done 10 times over 3 months.
Tetsuzo Agishi, Shinji Naganuma, Kazuo Ota   +2 more
openaire   +2 more sources

LDL Apheresis: A Novel Technique (LIPOCOLLECT 200)

Artificial Organs, 2009
AbstractTherapeutic means to lower Lp(a) are limited. The most effective method to reduce plasma Lp(a) concentration significantly is therapeutic apheresis, namely, low‐density lipoprotein (LDL) lipoprotein(a) (Lp(a)) apheresis. A novel technique based on reusable LDL adsorber called Lipocollect 200 (Medicollect, Rimbach, Germany) allows the removal of
STEFANUTTI, Claudia, DI GIACOMO S, MAZZARELLA, Bruno, CASTELLI A.   +3 more
openaire   +4 more sources

Effects of LDL apheresis on restenosis after angioplasty

Chemistry and Physics of Lipids, 1994
We performed long-term maintenance LDL apheresis therapy on patients with hypercholesterolemia after undergoing PTCA, and investigated the therapeutic effects of reducing serum cholesterol, LDL-cholesterol and Lp(a). LDL apheresis significantly reduced serum lipids and was an efficacious therapy in the prevention of recurrent stenosis after PTCA.
Noboru Tekekoshi, Seiyu Kanemitsu, Eiji Murakami   +2 more
openaire   +3 more sources

Efficacy criteria and cholesterol targets for LDL apheresis

Atherosclerosis, 2010
Low density lipoprotein (LDL) apheresis is now accepted as the treatment of choice for patients with homozygous familial hypercholesterolaemia and for heterozygotes with cardiovascular disease refractory to lipid-lowering drug therapy. However, a paucity of evidence has meant that detailed guidance on the extent of cholesterol reduction required to ...
C. Tyler, M. Gesinde, D. Scullard, P. Mandry, D. Davies, P. Dobral, Mahmoud Barbir, Alison Pottle, Gilbert R. Thompson, M. Livingston, C. W. le Roux, A.D. Marais, Suzanne Watkins, Clare Neuwirth, Stephanie Beatrix Matthews   +14 more
openaire   +3 more sources